Search Results - "Loder E"

Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.

Authors: Mannix, L.K. Loder, E. Nett, R. et al.

Source: Cephalalgia. May2007, Vol. 27 Issue 5, p414-421. 8p.

Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Authors: Silberstein, S. Loder, E. Diamond, S. et al.

Source: Cephalalgia. Mar2007, Vol. 27 Issue 3, p220-229. 10p. 5 Charts, 1 Graph.

Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack study.

Authors: Martin, V. T. Loder, E. Taylor, K. et al.

Source: Cephalalgia. Sep2005, Vol. 25 Issue 9, p726-734. 9p.

Menstrual migraine: clinical considerations in light of revised diagnostic criteria.

Authors: Loder, E.

Source: Neurological Sciences. May2005 Supplement 2, Vol. 26, p121-124. 4p.

Subjects: Migraine, Cluster headache, Menstrual cycle, Prognosis, Pain, Diagnosis

Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.

Authors: Loder, E. Goldstein, R. Biondi, D.

Source: Cephalalgia. Feb2005, Vol. 25 Issue 2, p124-131. 8p.

What is the evolutionary advantage of migraine?

Authors: Loder, E¹

Source: Cephalalgia. Oct2002, Vol. 22 Issue 8, p624-632. 9p.

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.

Authors: Ferrari, Md Loder, E McCarroll, Ka et al.

Source: Cephalalgia. Mar2001, Vol. 21 Issue 2, p129-136. 8p.

Beta-blockers for migraine.

Authors: Evans RW Rizzoli P Loder E et al.

Source: Headache: The Journal of Head & Face Pain. Mar2008, Vol. 48 Issue 3, p455-460. 6p.

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the american migraine prevalence and prevention study.

Authors: Diamond S Bigal ME Silberstein S et al.

Source: Headache: The Journal of Head & Face Pain. Mar2007, Vol. 47 Issue 3, p355-363. 9p.

Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.

Authors: Loder E Silberstein SD Abu-Shakra S et al.

Source: Headache: The Journal of Head & Face Pain. Feb2004, Vol. 44 Issue 2, p120-130. 11p.

Safety of sumatriptan in pregnancy: a review of the data so far.

Authors: Loder, E. Loder, Elizabeth

Source: CNS Drugs. 2003, Vol. 17 Issue 1, p1-7. 7p. 2 Charts.

Subjects: Sumatriptan, Headache treatment, Migraine, Pregnancy, Therapeutics

Manual therapy versus usual GP care for chronic tension-type headache: We now have better evidence, but important questions remain.

Authors: Loder E (AUTHOR)

Source: Cephalalgia. Jan2011, Vol. 31 Issue 2, p131-132. 2p.

Rehabilitation hospital staff knowledge and attitudes regarding pain.

Authors: Loder, E. Witkower, A. McAlary, P. et al.

Source: American Journal of Physical Medicine & Rehabilitation. Jan 2003: Vol. 82 Issue 1. p. 65-68-68.

This result is not displayed to guests.
Login for full access.

Missing clinical trial data: setting the record straight [corrected] [published erratum appears in BMJ 2011 Feb 19;342(7794):432].

Authors: Loder E Godlee F

Source: BMJ: British Medical Journal (Overseas & Retired Doctors Edition). 10/16/2010, Vol. 341 Issue 7777, pc5641-c5641. 1p.

Predatory Journals: What Can We Do to Protect Their Prey?

Authors: Laine, C. Babski, D. Bachelet, V. C. et al.

Source: Deutsches Ärzteblatt International. 1/24/2025, Vol. 122 Issue 2, p31-32. 2p.

Review: several drugs, especially triptans, are effective for pain relief in acute migraine.

Authors: Loder E (AUTHOR)

Source: ACP Journal Club. Nov/Dec2002, Vol. 137 Issue 3, p103-103. 1p.

URL: 8718558

Body mass index and episodic headaches: a population-based study.

Authors: Bigal ME Tsang A Loder E et al.

Source: Archives of Internal Medicine. 10/8/2007, Vol. 167 Issue 18, p1964-1970. 7p.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.

Authors: Husereau, D Drummond, M Augustovski, F et al.

Source: BJOG: An International Journal of Obstetrics & Gynaecology. Feb2022, Vol. 129 Issue 3, p336-344. 9p.

Evaluation and registration of adverse events in clinical drug trials in migraine.

Authors: Tfelt-Hansen, P Bjarnason, NH Dahlöf, C et al.

Source: Cephalalgia. Jul2008, Vol. 28 Issue 7, p683-688. 6p.